Follow

Xbrane Biopharma AB

Nasdaq First North GM Stockholm (Sweden)

Xbrane Biopharma develops and manufactures biosimilars and generic long-acting injectables. It offers products including Spherotide, for the treatment of prostate cancer, breast cancer, endometriosis, and myoma and Xlucane, a ranibizumab biosimilar for the treatment of age-related macular degeneration, diabetes-related macular edema, diabetic retinopathy, and retinal vein occlusion.

Sector:
HEALTH CARE
>
Biotechnology
Media
Status
This company has moved to a main market, therfore we do not show updates relating to this company.
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
XBRANE
SE0007789409
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Xbrane Biopharma AB with ticker XBRANE
Status
Active
Currency
SEK
First trading date
03 Feb 2016
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
XBRANE
SE0005795028
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Xbrane Biopharma AB with ticker XBRANE
Status
Archived
Currency
SEK
First trading date
03 Feb 2016
Type
Ticker
ISIN
Market
SHARE
XBRANE
SE0007789409
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Xbrane Biopharma AB with ticker XBRANE
Status
Active
Currency
SEK
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
People
Karl Martin Erik Åmark
CEO
Anders Tullgren
Chairman of the board
Anders Tullgren
Board member
Saeid Esmaeilzadeh
Board member
Maris Hartmanis
Board member
Karin Wingstrand
Board member
Peter Edman
Board member
Giorgi Chirivi
Board member
Alessandro Sidoli
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Banvaktsvägen 22
Zip code
171 48
City/district
Solna
Country
Sweden (SE)
Registration number
556749-2375
LEI code
5493008DKD05APTKQO39
First trade date
03 Feb 2016
Registration date
15 Jan 2008
Short name
XBRANE

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More